Ac Immune
(NASDAQ) ACIU
Ac Immune Financials at a Glance
Market Cap
$238.15M
Revenue (TTM)
CHF 3.70M
Net Income (TTM)
-CHF 66.22M
EPS (TTM)
-$0.82
P/E Ratio
-2.85
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.35
Volume
59,349.756
Open
$2.37
Price
$2.35
Volume
59,349.756
Open
$2.37
Previous Close
$2.34
Daily Range
$2.31 - $2.40
52-Week Range
$1.65 - $4.00
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.35
Volume
59,349.756
Open
$2.37
Previous Close
$2.34
Daily Range
$2.31 - $2.40
52-Week Range
$1.65 - $4.00
Estimated Earnings Date
Jul 30, 2026
ACIU News
Why AC Immune Stock Surged Today
Why AC Immune SA Is Imploding
ACIU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ac Immune
Industry
Biotechnology
Sector
Health CareEmployees
122
CEO
Andrea Pfeifer, PhD
Website
www.acimmune.comHeadquarters
Lausanne, 1015, CH
ACIU Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-17%
Net Income Margin
-18%
Return on Equity
-112%
Return on Capital
-1%
Return on Assets
-48%
Earnings Yield
-35.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$238.15M
Shares Outstanding
101.77M
Volume
59.35K
Avg. Volume
274.21K
Financials (TTM)
Gross Profit
CHF 3.57M
Operating Income
-CHF 68.86M
EBITDA
-CHF 67.75M
Operating Cash Flow
-CHF 66.15M
Capital Expenditure
-CHF 859.54K
Free Cash Flow
-CHF 67.01M
Cash & ST Invst.
CHF 91.52M
Total Debt
CHF 4.55M
Ac Immune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CHF 1.12M
+13.0%
Gross Profit
CHF 1.12M
+13.0%
Gross Margin
100.00%
N/A
Market Cap
$238.15M
N/A
Market Cap/Employee
$1.79M
N/A
Employees
133
N/A
Net Income
-CHF 14.80M
+22.2%
EBITDA
-CHF 14.74M
+19.8%
Quarterly Fundamentals
Total Cash
CHF 74.80M
-48.6%
Total Debt
CHF 4.30M
-16.8%
Accounts Receivable
CHF 1.51M
+63.5%
Inventory
CHF 0.00
N/A
Long Term Debt
CHF 3.48M
-16.0%
Short Term Debt
CHF 825.00K
-20.1%
Return on Assets
-48.19%
N/A
Return on Invested Capital
-1.43%
N/A
Free Cash Flow
-CHF 16.55M
-383.3%
Operating Cash Flow
-CHF 16.45M
-377.2%